# Amgen (AMGN) — Overview

AMGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/amgn

## Price

Last close $415.99 on Oct 13, 2026. 52-week range $291.16 – $444.12.

## Company profile

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis, which has been further strengthened with the launch of new drugs in blood cancers (Blincyto) and solid tumors (Imdelltra). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $38.1B |
| Revenue (quarter) | $10.1B |
| Revenue growth (year over year) | 9.53% |
| Gross profit (trailing twelve months) | $26.5B |
| Gross margin | 69.52% |
| Net income (trailing twelve months) | $8.7B |
| Net income (quarter) | $2.4B |
| Net income growth (year over year) | 65.85% |
| Net margin | 22.95% |
| Return on equity | 91.47% |
| EPS (trailing twelve months) | $16.22 |
| Book value per share | $21.62 |
| P/E (trailing twelve months) | 25.7 |
| Price to book | 19.2 |
| Debt to assets | 87.78% |
| Payout ratio | 66.41% |
| Dividend yield | 2.39% |

## Frequently Asked Questions

### Is Amgen (AMGN) profitable?

Yes. Amgen earned $8.7B in net income over the trailing twelve months, a net margin of 22.95%.

### How much revenue does Amgen (AMGN) make?

Amgen generated $38.1B in revenue over the trailing twelve months, up 9.53% year over year.

### What is AMGN's P/E ratio?

Amgen trades at 25.7 times trailing twelve-month earnings, on an EPS of $16.22.

### How do I buy stock in Amgen (AMGN)?

AMGN trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock
- [GILD](https://www.lighthorse.io/tickers/gild) — Gilead Sciences, Inc. - Common Stock
- [VRTX](https://www.lighthorse.io/tickers/vrtx) — Vertex Pharmaceuticals Incorporated - Common Stock
- [MRK](https://www.lighthorse.io/tickers/mrk) — Merck & Company, Inc. Common Stock (new)
- [AZN](https://www.lighthorse.io/tickers/azn) — AstraZeneca PLC Ordinary Shares
- [LLY](https://www.lighthorse.io/tickers/lly) — Eli Lilly and Company Common Stock
- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock
- [BMY](https://www.lighthorse.io/tickers/bmy) — Bristol-Myers Squibb Company Common Stock
- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock
- [REGN](https://www.lighthorse.io/tickers/regn) — Regeneron Pharmaceuticals, Inc. - Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).